Skip to main content

Table 3 Number of respondents who report being advised about possible risks of PSA testing

From: Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure

Received advice about potential risk (n = 188) n (%) 95% CI for% Missing values
No clear evidence that PSA testing saves lives 60 (35%) (27.5, 41.8) 15
PSA testing can lead to unnecessary treatments 28 (17%) (11.4, 23.2) 26
Treatment for prostate cancer can lead to incontinence 45 (29%) (22.0, 36.5) 34
Treatment for prostate cancer can lead to erectile dysfunction 53 (33%) (25.8, 40.5) 28
Most prostate cancers will not affect a man’s health during his lifetime 65 (38%) (30.5, 45.1) 16